Cargando…

Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach

PURPOSE: This study aims to evaluate the quality of the Finnish clinical practice guideline related to schizophrenia care and how it can be utilized in psychiatric services. PARTICIPANTS AND METHODS: The data were collected from one psychiatric ward and seven psychiatric outpatient units situated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vähäniemi, Anu, Välimäki, Maritta, Pekurinen, Virve, Anttila, Minna, Lantta, Tella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512783/
https://www.ncbi.nlm.nih.gov/pubmed/31190830
http://dx.doi.org/10.2147/NDT.S192752
_version_ 1783417697513504768
author Vähäniemi, Anu
Välimäki, Maritta
Pekurinen, Virve
Anttila, Minna
Lantta, Tella
author_facet Vähäniemi, Anu
Välimäki, Maritta
Pekurinen, Virve
Anttila, Minna
Lantta, Tella
author_sort Vähäniemi, Anu
collection PubMed
description PURPOSE: This study aims to evaluate the quality of the Finnish clinical practice guideline related to schizophrenia care and how it can be utilized in psychiatric services. PARTICIPANTS AND METHODS: The data were collected from one psychiatric ward and seven psychiatric outpatient units situated in two cities in Southern Finland. A total of 49 professionals working in these sites participated in this study. A descriptive study design was adopted. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument with six domains including 23 items was used to assess the quality of the guideline, whereas a vignette was implemented to describe how staff would use the guideline in hypothetical cases in daily practice. The analysis of AGREE II was based on rating each of the 23 items on a seven-point scale and calculating a quality score for the six domains. To describe the utilization of the guideline, eight key recommendations of the guideline were deductively rated out of the respondents’ answers. RESULTS: The results showed that the “scope and purpose” of the guideline were well described, but “applicability” was insufficient. The overall quality of the guideline was high (73%). Almost one fifth of the respondents were in agreement with key recommendations. CONCLUSION: The overall quality of Guideline for Schizophrenia was good, but its “applicability” and utilization should be improved.
format Online
Article
Text
id pubmed-6512783
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-65127832019-06-12 Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach Vähäniemi, Anu Välimäki, Maritta Pekurinen, Virve Anttila, Minna Lantta, Tella Neuropsychiatr Dis Treat Original Research PURPOSE: This study aims to evaluate the quality of the Finnish clinical practice guideline related to schizophrenia care and how it can be utilized in psychiatric services. PARTICIPANTS AND METHODS: The data were collected from one psychiatric ward and seven psychiatric outpatient units situated in two cities in Southern Finland. A total of 49 professionals working in these sites participated in this study. A descriptive study design was adopted. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument with six domains including 23 items was used to assess the quality of the guideline, whereas a vignette was implemented to describe how staff would use the guideline in hypothetical cases in daily practice. The analysis of AGREE II was based on rating each of the 23 items on a seven-point scale and calculating a quality score for the six domains. To describe the utilization of the guideline, eight key recommendations of the guideline were deductively rated out of the respondents’ answers. RESULTS: The results showed that the “scope and purpose” of the guideline were well described, but “applicability” was insufficient. The overall quality of the guideline was high (73%). Almost one fifth of the respondents were in agreement with key recommendations. CONCLUSION: The overall quality of Guideline for Schizophrenia was good, but its “applicability” and utilization should be improved. Dove Medical Press 2019-05-09 /pmc/articles/PMC6512783/ /pubmed/31190830 http://dx.doi.org/10.2147/NDT.S192752 Text en © 2019 Vähäniemi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Vähäniemi, Anu
Välimäki, Maritta
Pekurinen, Virve
Anttila, Minna
Lantta, Tella
Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
title Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
title_full Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
title_fullStr Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
title_full_unstemmed Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
title_short Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
title_sort quality and utilization of the finnish clinical practice guideline in schizophrenia: evaluation using agree ii and the vignette approach
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512783/
https://www.ncbi.nlm.nih.gov/pubmed/31190830
http://dx.doi.org/10.2147/NDT.S192752
work_keys_str_mv AT vahaniemianu qualityandutilizationofthefinnishclinicalpracticeguidelineinschizophreniaevaluationusingagreeiiandthevignetteapproach
AT valimakimaritta qualityandutilizationofthefinnishclinicalpracticeguidelineinschizophreniaevaluationusingagreeiiandthevignetteapproach
AT pekurinenvirve qualityandutilizationofthefinnishclinicalpracticeguidelineinschizophreniaevaluationusingagreeiiandthevignetteapproach
AT anttilaminna qualityandutilizationofthefinnishclinicalpracticeguidelineinschizophreniaevaluationusingagreeiiandthevignetteapproach
AT lanttatella qualityandutilizationofthefinnishclinicalpracticeguidelineinschizophreniaevaluationusingagreeiiandthevignetteapproach